Advertisement

Geriatrie-Report

, Volume 14, Issue 4, pp 16–19 | Cite as

Bedrohliche Komorbidität

Alt, schwach und herzinsuffizient? Denken Sie an die Sarkopenie!

  • Philipp BergmannEmail author
  • Corinna Geisler
Kardiologie
  • 11 Downloads

Die Sarkopenie ist eng mit der Herzinsuffizienz assoziiert und trägt zu einer ungünstigen Prognose bei. Doch gerade die typischen Symptome der Herzinsuffizienz erschweren es, den Muskelschwund zu erkennen.

Literatur

  1. 1.
    Rosenberg IH (2011) Sarcopenia: origins and clinical relevance. Clinics in geriatric medicine 27:337–339.CrossRefGoogle Scholar
  2. 2.
    Cruz-Jentoft AJ, Bahat G, Bauer J et al. (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing 48:16–31.CrossRefGoogle Scholar
  3. 3.
    Beaudart C, McCloskey E, Bruyère O et al. (2016) Sarcopenia in daily practice: assessment and man-agement. BMC geriatrics 16:170.CrossRefGoogle Scholar
  4. 4.
    Bekfani T, Pellicori P, Morris DA et al. (2016) Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life. International journal of cardiology 222:41–46.CrossRefGoogle Scholar
  5. 5.
    Mangner N, Weikert B, Bowen TS et al. (2015) Skeletal muscle alterations in chronic heart failure: differential effects on quadriceps and diaphragm. Journal of cachexia, sarcopenia and muscle 6:381–390.CrossRefGoogle Scholar
  6. 6.
    King D, Smith ML, Chapman TJ, Stockdale HR, Lye M (1996) Fat malabsorption in elderly patients with cardiac cachexia. Age and ageing 25:144–149.CrossRefGoogle Scholar
  7. 7.
    King D, Smith ML, Lye M (1996) Gastro-intestinal protein loss in elderly patients with cardiac cachexia. Age and ageing 25:221–223.CrossRefGoogle Scholar
  8. 8.
    Anker SD, Egerer KR, Volk H-D, Kox WJ, Poole-Wilson PA, Coats AJS (1997) Elevated soluble CD14 re-ceptors and altered cytokines in chronic heart failure. The American Journal of Cardiology 79:1426–1430.CrossRefGoogle Scholar
  9. 9.
    McMurray JJV, Adamopoulos S, Anker SD et al. (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European journal of heart failure 14:803–869.CrossRefGoogle Scholar
  10. 10.
    Anker SD, Negassa A, Coats AJS et al. (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. The Lancet 361:1077–1083.CrossRefGoogle Scholar
  11. 11.
    Biesalski HK, Bischoff SC, Pirlich M, Weimann A (2018) Ernährungsmedizin. Kapitel 56: Kardiale und pulmonale Kachexie.Google Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Klinik für Innere Medizin I Bereich AltersmedizinUniversitätsklinikum Schleswig-HolsteinKielDeutschland
  2. 2.Endokrinologie, Diabetologie und Klinische ErnährungsmedizinUKSHKielDeutschland

Personalised recommendations